However, GRAPPA asserts that there is grade A evidence for use of infliximab or etanercept in severe enthesitis ... the target of all treatment strategies in psoriatic arthritis.

PsA is a chronic, inflammatory disease in and around the joints as well as the surrounding tendons and ligaments. It is ...

Guidance particularly addresses the value of ultrasound in patient-provider shared decision-making in management of care.

Low patient satisfaction in psoriasis and psoriatic arthritis for clinicians and treatment is tied to need for better ...

MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.

and experience a more severe disease course. But thanks to advances in PsA treatments, most disease complications can be avoided. Juvenile psoriatic arthritis is a type of juvenile idiopathic ...

The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

Psoriatic arthritis can be mild or severe. It can also be somewhere in between. But it’s important to understand that it’s a progressive disease. Although there are some very effective treatments to ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...